Losartan

angiotensinogen ; Homo sapiens







539 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
201 12610022 Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation. 2003 Mar 1
202 12612946 Recent advances in management of type 2 diabetes and nephropathy: lessons from the RENAAL study. 2003 Mar 1
203 12614193 ACE inhibitors or AT-1 antagonists - which is OPTIMAAL after acute myocardial infarction? 2003 Mar 1
204 12631367 The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. 2003 Apr 1
205 12675278 Screening and identification of the up-regulated genes in human mesangial cells exposed to angiotensin II. 2003 Mar 2
206 12676173 Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. 2003 Jun 2
207 12710529 Angiotensin-II-induced enhanced expression of Gi proteins is attenuated by losartan in A10 vascular smooth muscle cells: role of AT1 receptors. 2003 Feb 1
208 12716796 Analysis of metabolic parameters as predictors of risk in the RENAAL study. 2003 May 2
209 12733824 Angiotensin II and its receptors in human endocardial endothelial cells: role in modulating intracellular calcium. 2003 Mar 1
210 12749912 Angiotensin II-induced ionic currents and signalling pathways in submandibular ganglion neurons. 2003 Jun 1
211 12761244 AngRem104, an angiotensin II-induced novel upregulated gene in human mesangial cells, is potentially involved in the regulation of fibronectin expression. 2003 Jun 2
212 12763754 Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of AKT/PKB. 2003 Sep 1
213 12811831 Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. 2003 Aug 1
214 12873796 Further studies on the effect of intracellular angiotensins on heart cell communication: on the role of endogenous angiotensin II. 2003 Aug 15 1
215 14510783 Facilitation of renal autoregulation by angiotensin II is mediated through modulation of nitric oxide. 2003 Oct 1
216 14575590 [Effect of angiotensin II on tissue factor expression in human peripheral blood monocytes and its mechanisms]. 2003 Sep 1
217 14652437 Effect of losartan on albuminuria, peripheral and autonomic neuropathy in normotensive microalbuminuric type 2 diabetics. 2003 Sep 1
218 14669746 ACE-inhibition and angiotensin II receptor blockers in chronic heart failure: pathophysiological consideration of the unresolved battle. 2003 May 1
219 14728071 Losartan: in the reduction of stroke risk in patients with hypertension and left ventricular hypertrophy. 2003 2
220 14749145 Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence. 2003 Dec 2
221 15107595 Cardiovascular drugs and serum uric acid. 2003 Sep-Nov 1
222 11749656 Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart. 2002 Jan 1
223 11791032 Effects of losartan and its combination with quinapril on the cardiac sympathetic nervous system and neurohormonal status in essential hypertension. 2002 Jan 1
224 11805174 Variation in the renin angiotensin system throughout the normal menstrual cycle. 2002 Feb 1
225 11814138 Improving the managed care of hypertension with angiotensin II antagonists. 2002 Jan 1
226 11824874 Use of angiotensin II receptor blockers in animal models of atherosclerosis. 2002 Jan 1
227 11850771 Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients. 2002 Feb 2
228 11867945 Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease. 2002 Mar 1
229 11901904 [The best of 2001. Arterial hypertension]. 2002 Jan 1
230 11963637 [Efficacy-safety relationship of AT1 angiotensin II receptor antagonists: current data]. 2002 Jan-Feb 1
231 11964369 Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179. 2002 Apr 19 1
232 11971755 Losartan decreases glomerular filtration rate in isolated perfused porcine slaughterhouse kidneys. 2002 Mar-Apr 2
233 11973418 Inhibition of vascular smooth muscle cell growth by angiotensin type 2 receptor stimulation for in vitro organ culture model. 2002 May 1
234 11996945 Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties. 2002 Jun 1
235 12021402 Site-directed mutagenesis of the gerbil and human angiotensin II AT(1) receptors identifies amino acid residues attributable to the binding affinity for the nonpeptidic antagonist losartan. 2002 Jun 1
236 12021572 Angiotensin II and IV stimulate expression and release of plasminogen activator inhibitor-1 in cultured human coronary artery endothelial cells. 2002 Jun 2
237 12031795 Angiotensin II activation of focal adhesion kinase and pp60c-Src in relation to mitogen-activated protein kinases in hepatocytes. 2002 May 8 3
238 12063990 Effects of losartan, somatostatin and losartan plus somatostatin on portal hemodynamics and renal functions in cirrhosis. 2002 May-Jun 1
239 12094823 The role of losartan in cost-effective hypertension control. 2002 1
240 12119058 Losartan and diabetic nephropathy: commentaries on the RENAAL study. 2002 Apr 8 1
241 12121010 Recent landmark clinical trials: how do they modify the therapeutic paradigm? 2002 Jul 1
242 12127057 AT1 angiotensin II receptor mediates intracellular calcium mobilization in normal and cancerous breast cells in primary culture. 2002 Jul 3
243 12140723 AT(1)-receptor blockers: differences that matter. 2002 Aug 2
244 12176659 Activation of angiotensin II type I receptor promotes protein kinase C translocation and cell proliferation in human cultured breast epithelial cells. 2002 Aug 4
245 12182249 The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies. 2002 Jul 1
246 12182261 Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study. 2002 Jul 1
247 12195129 Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy. 2002 Sep 2
248 12208167 Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists. 2002 Sep 1
249 12214151 Effects of a long-term pharmacological interruption of the renin-angiotensin system on the fibrinolytic system in essential hypertension. 2002 Mar-Apr 1
250 12234601 Antagonist interaction with endogenous AT(1) receptors in human cell lines. 2002 Oct 15 1